{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:41:09Z","timestamp":1770820869493,"version":"3.50.1"},"reference-count":88,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T00:00:00Z","timestamp":1452470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0004356","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T19:03:53Z","timestamp":1452539033000},"page":"e0004356","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":62,"title":["Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoni"],"prefix":"10.1371","volume":"10","author":[{"given":"Thavy","family":"Long","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Jeffrey","family":"Neitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chakrapani","family":"Kalyanaraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian M.","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colette","family":"Dissous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"McKerrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Drewry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Zuercher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conor R.","family":"Caffrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,1,11]]},"reference":[{"key":"ref1","unstructured":"WHO. Schistosomiasis: Fact sheet N\u00b0115: WHO; 2014. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/mediacentre\/factsheets\/fs115\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/mediacentre\/factsheets\/fs115\/en\/<\/ext-link>."},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/cmdc.201000202","article-title":"Praziquantel and schistosomiasis","volume":"5","author":"A Domling","year":"2010","journal-title":"ChemMedChem"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00436-009-1546-2","article-title":"Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use","volume":"105","author":"RA Abdul-Ghani","year":"2009","journal-title":"Parasitol Res"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molbiopara.2014.06.002","article-title":"Schistosomiasis control: praziquantel forever?","volume":"195","author":"D Cioli","year":"2014","journal-title":"Mol Biochem Parasitol"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.4155\/fmc.15.27","article-title":"Schistosomiasis and its treatment","volume":"7","author":"CR Caffrey","year":"2015","journal-title":"Future Med Chem"},{"issue":"31","key":"ref6","doi-asserted-by":"crossref","first-page":"7936","DOI":"10.1002\/anie.201208390","article-title":"Schistosomiasis chemotherapy","volume":"52","author":"SA Thetiot-Laurent","year":"2013","journal-title":"Angew Chem Int Ed Engl"},{"issue":"6164","key":"ref7","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1126\/science.1243106","article-title":"Genetic and molecular basis of drug resistance and species-specific drug action in schistosome parasites","volume":"342","author":"CL Valentim","year":"2013","journal-title":"Science"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00436-012-3151-z","article-title":"Susceptibility or resistance of praziquantel in human schistosomiasis: a review","volume":"111","author":"W Wang","year":"2012","journal-title":"Parasitol Res"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbiopara.2008.11.007","article-title":"Towards an understanding of the mechanism of action of praziquantel","volume":"164","author":"AD Aragon","year":"2009","journal-title":"Mol Biochem Parasitol"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/QCO.0b013e328318978f","article-title":"Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis","volume":"21","author":"MJ Doenhoff","year":"2008","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/QCO.0b013e328349156f","article-title":"Schistosomiasis: from drug deployment to drug development","volume":"24","author":"CR Caffrey","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jac\/dkt491","article-title":"The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer)","volume":"69","author":"P Olliaro","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF03189504","article-title":"Metabolism of praziquantel in man","volume":"3","author":"KU Buhring","year":"1978","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/med.2610030204","article-title":"Praziquantel","volume":"3","author":"P Andrews","year":"1983","journal-title":"Med Res Rev"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0014-4894(86)90184-0","article-title":"Schistosoma mansoni: chemotherapy of infections of different ages","volume":"61","author":"AA Sabah","year":"1986","journal-title":"Exp Parasitol"},{"issue":"9","key":"ref16","first-page":"759","article-title":"Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel","volume":"100","author":"SH Xiao","year":"1987","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1371\/journal.pntd.0000357","article-title":"Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment","volume":"3","author":"T Meyer","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1645\/14-703.1","article-title":"Anthelmintic drug discovery: into the future","volume":"101","author":"TG Geary","year":"2015","journal-title":"J Parasitol"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3390\/molecules20021872","article-title":"Natural products as leads in schistosome drug discovery","volume":"20","author":"BJ Neves","year":"2015","journal-title":"Molecules"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"e87594","DOI":"10.1371\/journal.pone.0087594","article-title":"Chemical and genetic validation of the statin drug target to treat the helminth disease, schistosomiasis","volume":"9","author":"L Rojo-Arreola","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1128\/AAC.04601-14","article-title":"Synthesis of a Sugar-Based Thiosemicarbazone Series and Structure-Activity Relationship versus the Parasite Cysteine Proteases Rhodesain, Cruzain, and Schistosoma mansoni Cathepsin B1","volume":"59","author":"NC Fonseca","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1177\/1087057115569155","article-title":"Repurposing of the Open Access Malaria Box for Kinetoplastid Diseases Identifies Novel Active Scaffolds against Trypanosomatids","volume":"20","author":"M Kaiser","year":"2015","journal-title":"J Biomol Screen"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1039\/C4MD00045E","article-title":"Repurposing human Aurora kinase inhibitors as leads for anti-protozoan drug discovery","volume":"5","author":"G Patel","year":"2014","journal-title":"MedChemComm"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijpddr.2014.09.004","article-title":"Compound library screening identified Akt\/PKB kinase pathway inhibitors as potential key molecules for the development of new chemotherapeutics against schistosomiasis","volume":"4","author":"M Morel","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nchembio806","article-title":"Jr. A clinical drug library screen identifies astemizole as an antimalarial agent","volume":"2","author":"CR Chong","year":"2006","journal-title":"Nat Chem Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1471-2164-12-215","article-title":"Eukaryotic protein kinases (ePKs) of the helminth parasite Schistosoma mansoni","volume":"12","author":"LF Andrade","year":"2011","journal-title":"BMC Genomics"},{"key":"ref27","article-title":"Targeting kinases in Plasmodium and Schistosoma: Same goals, different challenges","author":"C Doerig","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"ref28","first-page":"3579","article-title":"Protein kinases as potential targets for novel anti-schistosomal strategies","volume":"18","author":"S Beckmann","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"e0003801","DOI":"10.1371\/journal.pntd.0003801","article-title":"Application of RNAi to Genomic Drug Target Validation in Schistosomes","volume":"9","author":"A Guidi","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17460441.2015.962510","article-title":"Thoughts on the current assessment of Polo-like kinase inhibitor drug discovery","volume":"10","author":"K Strebhardt","year":"2015","journal-title":"Expert Opin Drug Discov"},{"issue":"23","key":"ref31","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.2174\/092986712802002455","article-title":"Polo-like kinases inhibitors","volume":"19","author":"L Garuti","year":"2012","journal-title":"Curr Med Chem"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/leu.2014.222","article-title":"Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy","volume":"29","author":"BT Gjertsen","year":"2015","journal-title":"Leukemia"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cub.2006.12.046","article-title":"The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1","volume":"17","author":"P Lenart","year":"2007","journal-title":"Curr Biol"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cub.2006.12.037","article-title":"BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo","volume":"17","author":"M Steegmaier","year":"2007","journal-title":"Curr Biol"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.ajpath.2011.06.031","article-title":"Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo","volume":"179","author":"J Yuan","year":"2011","journal-title":"Am J Pathol"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/cbic.200900059","article-title":"A pan-specific inhibitor of the polo-box domains of polo-like kinases arrests cancer cells in mitosis","volume":"10","author":"W Reindl","year":"2009","journal-title":"Chembiochem"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"e40045","DOI":"10.1371\/journal.pone.0040045","article-title":"SmSak, the second Polo-like kinase of the helminth parasite Schistosoma mansoni: conserved and unexpected roles in meiosis","volume":"7","author":"T Long","year":"2012","journal-title":"PLoS ONE"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1590\/S0001-37652011000200022","article-title":"Schistosoma mansoni Polo-like kinases and their function in control of mitosis and parasite reproduction","volume":"83","author":"C Dissous","year":"2011","journal-title":"An Acad Bras Cienc"},{"issue":"9","key":"ref39","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ijpara.2010.03.002","article-title":"Schistosoma mansoni Polo-like kinase 1: A mitotic kinase with key functions in parasite reproduction","volume":"40","author":"T Long","year":"2010","journal-title":"Int J Parasitol"},{"key":"ref40","article-title":"Understanding the Polo Kinase machine","author":"V Archambault","year":"2015","journal-title":"Oncogene"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/gb-2008-9-1-203","article-title":"Yeast Polo-like kinase substrates are nailed with the right tools","volume":"9","author":"V Archambault","year":"2008","journal-title":"Genome Biol"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrm2653","article-title":"Polo-like kinases: conservation and divergence in their functions and regulation","volume":"10","author":"V Archambault","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrm1401","article-title":"Polo-like kinases and the orchestration of cell division","volume":"5","author":"FA Barr","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"ref44","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrm3819","article-title":"Polo-like kinases: structural variations lead to multiple functions","volume":"15","author":"S Zitouni","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"ref45","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrd3184","article-title":"Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy","volume":"9","author":"K Strebhardt","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"14","key":"ref46","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.4161\/cc.10.14.16494","article-title":"From Plk1 to Plk5: functional evolution of polo-like kinases","volume":"10","author":"G de Carcer","year":"2011","journal-title":"Cell cycle"},{"issue":"10","key":"ref47","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2174\/1381612820999141029162811","article-title":"Polo-like kinase 1 as a potential therapeutic target for osteosarcoma","volume":"21","author":"L Cheng","year":"2015","journal-title":"Curr Pharm Des"},{"issue":"7","key":"ref48","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1517\/17460441.2014.918100","article-title":"Current assessment of polo-like kinases as anti-tumor drug targets","volume":"9","author":"SN Craig","year":"2014","journal-title":"Expert Opin Drug Discov"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.onc.1208272","article-title":"Polo-like kinases (Plks) and cancer","volume":"24","author":"N Takai","year":"2005","journal-title":"Oncogene"},{"key":"ref50","article-title":"Nat Biotechnol","author":"JM Elkins","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.bmcl.2008.11.041","article-title":"Discovery of thiophene inhibitors of polo-like kinase","volume":"19","author":"KA Emmitte","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.bmcl.2009.01.094","article-title":"Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding","volume":"19","author":"KA Emmitte","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"issue":"15","key":"ref53","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1016\/j.bmcl.2010.06.009","article-title":"Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties","volume":"20","author":"TR Rheault","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1371\/journal.pmed.0040014","article-title":"Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor","volume":"4","author":"MH Abdulla","year":"2007","journal-title":"PLoS Med"},{"issue":"7","key":"ref55","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1371\/journal.pntd.0000478","article-title":"Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening","volume":"3","author":"MH Abdulla","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0014-4894(74)90005-8","article-title":"Schistosoma mansoni: simplified method for the production of schistosomules","volume":"35","author":"DG Colley","year":"1974","journal-title":"Exp Parasitol"},{"issue":"10","key":"ref57","doi-asserted-by":"crossref","first-page":"e850","DOI":"10.1371\/journal.pntd.0000850","article-title":"RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening","volume":"4","author":"S Stefanic","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4269\/ajtmh.1967.16.483","article-title":"An improved perfusion technique for recovering adult schistosomes from laboratory animals","volume":"16","author":"RH Duvall","year":"1967","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"ref59","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2307\/3280632","article-title":"Cultivation of Schistosoma mansoni in vitro. I. Establishment of cultures from cercariae and development until pairing","volume":"67","author":"PF Basch","year":"1981","journal-title":"J Parasitol"},{"issue":"6","key":"ref60","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1371\/journal.pntd.0000449","article-title":"SmCL3, a gastrodermal cysteine protease of the human blood fluke Schistosoma mansoni","volume":"3","author":"J Dvorak","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"ref61","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"issue":"3","key":"ref62","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijpddr.2014.07.005","article-title":"Serum albumin and alpha-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor Imatinib","volume":"4","author":"S Beckmann","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Singh R, Pittas, M., I. Heskia, I., Xu, F., McKerrow, J. H., Caffrey, C. R. Automated image-based phenotypic screening for high-throughput drug discovery. <italic>IEEE Symposium on Computer-Based Medical Systems<\/italic> 2\u20135 August 2009 Albuquerque, NM 2009. p. 1\u20138.","DOI":"10.1109\/CBMS.2009.5255338"},{"issue":"6","key":"ref64","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1109\/TMI.2013.2247412","article-title":"Segmenting the etiological agent of schistosomiasis for high-content screening","volume":"32","author":"D Asarnow","year":"2013","journal-title":"IEEE Transactions on Medical Imaging"},{"key":"ref65","first-page":"44","article-title":"International Symposium on Visual Computing (ISVC): Lecture Notes in Computer Science","volume":"6938","author":"A Moody-Davis","year":"2011"},{"key":"ref66","first-page":"104","article-title":"Proceedings of the International Symposium on Visual Computing, Lecture Notes in Computer Science","volume":"7432","author":"U Saha","year":"2012"},{"key":"ref67","first-page":"13","article-title":"Quantification and clustering of phenotypic screening data using time-series analysis for chemotherapy of schistosomiasis","volume":"1","author":"H Lee","year":"2012","journal-title":"BMC Genomics"},{"issue":"7","key":"ref68","doi-asserted-by":"crossref","first-page":"e1762","DOI":"10.1371\/journal.pntd.0001762","article-title":"Whole organism high-content screening by label-free, image-based Bayesian classification for parasitic diseases","volume":"6","author":"RA Paveley","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"ref69","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/bioinformatics\/btu831","article-title":"The QDREC web server: determining dose-response characteristics of complex macroparasites in phenotypic drug screens","volume":"31","author":"D Asarnow","year":"2015","journal-title":"Bioinformatics"},{"issue":"6","key":"ref70","doi-asserted-by":"crossref","first-page":"10873","DOI":"10.3390\/molecules200610873","article-title":"Anti-Schistosomal Activity of Cinnamic Acid Esters: Eugenyl and Thymyl Cinnamate Induce Cytoplasmic Vacuoles and Death in Schistosomula of Schistosoma mansoni","volume":"20","author":"J Glaser","year":"2015","journal-title":"Molecules"},{"key":"ref71","article-title":"Algorithms for Clustering Data","author":"R Jain","year":"1988"},{"issue":"3","key":"ref72","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1124\/jpet.114.221150","article-title":"Efficacy and mechanism of action of volasertib, a potent and selective inhibitor of Polo-like kinases, in preclinical models of acute myeloid leukemia","volume":"352","author":"D Rudolph","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"ref73","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1158\/1078-0432.CCR-08-2445","article-title":"BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity","volume":"15","author":"D Rudolph","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"7","key":"ref74","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2217\/fon.14.53","article-title":"Volasertib for the treatment of acute myeloid leukemia: a review of preclinical and clinical development","volume":"10","author":"M Janning","year":"2014","journal-title":"Future Oncol"},{"issue":"17","key":"ref75","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1158\/0008-5472.CAN-09-0945","article-title":"Distinct concentration-dependent effects of the polo-like kinase 1-specific inhibitor GSK461364A, including differential effect on apoptosis","volume":"69","author":"AG Gilmartin","year":"2009","journal-title":"Cancer Res"},{"issue":"7","key":"ref76","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1158\/1535-7163.MCT-10-0095","article-title":"Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instability","volume":"9","author":"Y Degenhardt","year":"2010","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"ref77","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.chembiol.2008.03.013","article-title":"Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein-protein interactions","volume":"15","author":"W Reindl","year":"2008","journal-title":"Chem Biol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1517\/17460441.2.S1.S53","article-title":"Schistosomes: challenges in compound screening","volume":"2","author":"B Ramirez","year":"2007","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"ref79","doi-asserted-by":"crossref","first-page":"e2610","DOI":"10.1371\/journal.pntd.0002610","article-title":"Orally active antischistosomal early leads identified from the open access malaria box","volume":"8","author":"K Ingram-Sieber","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"ref80","doi-asserted-by":"crossref","first-page":"e505","DOI":"10.1371\/journal.pntd.0000505","article-title":"A schistosome cAMP-dependent protein kinase catalytic subunit Is essential for parasite viability","volume":"3","author":"BE Swierczewski","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"ref81","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1371\/journal.pmed.0040206","article-title":"Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target","volume":"4","author":"AN Kuntz","year":"2007","journal-title":"PLoS Med"},{"issue":"2","key":"ref82","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1158\/1535-7163.MCT-06-0543","article-title":"In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1","volume":"6","author":"TJ Lansing","year":"2007","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"ref83","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1158\/1078-0432.CCR-10-2946","article-title":"Phase I study of GSK461364, a specific and competitive Polo-like kinase 1 inhibitor, in patients with advanced solid malignancies","volume":"17","author":"D Olmos","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"1","key":"ref84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/14737159.7.1.1","article-title":"Drug discovery without a molecular target: the road less traveled","volume":"7","author":"P Ross-Macdonald","year":"2007","journal-title":"Expert Rev Mol Diagn"},{"issue":"7","key":"ref85","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrd3480","article-title":"How were new medicines discovered?","volume":"10","author":"DC Swinney","year":"2011","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"ref86","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrd4336","article-title":"The discovery of first-in-class drugs: origins and evolution","volume":"13","author":"J Eder","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"ref87","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1021\/jm201649s","article-title":"Modern phenotypic drug discovery is a viable, neoclassic pharma strategy","volume":"55","author":"JA Lee","year":"2012","journal-title":"J Med Chem"},{"key":"ref88","doi-asserted-by":"crossref","DOI":"10.1002\/9783527652969","article-title":"Parasitic Helminths: Targets, Screens, Drugs and Vaccines","author":"CR Caffrey","year":"2012"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0004356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T11:51:52Z","timestamp":1567511512000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0004356"}},"subtitle":[],"editor":[{"given":"Timothy G.","family":"Geary","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,1,11]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0004356","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,11]]}}}